EPS5.01 Change in gut microbiota following elexacaftor/tezacaftor/ivacaftor (ETI) therapy: preliminary analysis

Caley, L. orcid.org/0000-0001-8957-1018, de Goffau, M.C., Jones, A.M. et al. (6 more authors) (2023) EPS5.01 Change in gut microbiota following elexacaftor/tezacaftor/ivacaftor (ETI) therapy: preliminary analysis. In: Journal of Cystic Fibrosis. 46th European Cystic Fibrosis Conference, 07-10 Jun 2023, Vienna, Austria. Elsevier

Metadata

Item Type: Proceedings Paper
Authors/Creators:
Dates:
  • Published: June 2023
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Biological Sciences (Leeds) > Faculty of Biological Sciences Office (Leeds)
Funding Information:
Funder
Grant number
Cystic Fibrosis Trust
SRC012
Depositing User: Symplectic Publications
Date Deposited: 13 Jun 2025 16:15
Last Modified: 13 Jun 2025 16:15
Status: Published
Publisher: Elsevier
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)